# C_2020227EN.01001401.xml

| 10.7.2020 | EN | Official Journal of the European Union | C 227/14 |
| --- | --- | --- | --- |

10.7.2020

EN

Official Journal of the European Union

C 227/14

---

Prior notification of a concentration

(Case M.9897 — Actineo/SHAM/Antevis JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 227/10)

1.

On 3 July 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

| — | Société Hospitalière d'Assurances Mutuelles (‘SHAM’, France), |
| --- | --- |

—

Société Hospitalière d'Assurances Mutuelles (‘SHAM’, France),

| — | Actineo GmbH (‘Actineo’, Germany), |
| --- | --- |

—

Actineo GmbH (‘Actineo’, Germany),

| — | Antevis SAS (‘Antevis’, France) |
| --- | --- |

—

Antevis SAS (‘Antevis’, France)

SHAM and Actineo acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of Antevis.

The concentration is accomplished by way of purchase of shares.

2.

| — | SHAM: Non-life insurance, in particular medical malpractice insurance; |
| --- | --- |

—

SHAM: Non-life insurance, in particular medical malpractice insurance;

| — | Actineo: Services in holistic personal injury insurance management; |
| --- | --- |

—

Actineo: Services in holistic personal injury insurance management;

| — | Antevis: Services to medical malpractice insurers in the field of claims management (through the extraction and processing of medical data), medical evaluation services and development of medical malpractice bodily injury claims risks analysis and scoring models. |
| --- | --- |

—

Antevis: Services to medical malpractice insurers in the field of claims management (through the extraction and processing of medical data), medical evaluation services and development of medical malpractice bodily injury claims risks analysis and scoring models.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9897 – Actineo/SHAM/Antevis JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---